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Abstract
Background: Many people attending rheumatology clinics use analgesics and non-steroidal anti-
inflammatories for persistent musculoskeletal pain. Guidelines for pain management recommend
regular and pre-emptive use of analgesics to reduce the impact of pain. Clinical experience indicates
that analgesics are often not used in this way. Studies exploring use of analgesics in arthritis have
historically measured adherence to such medication. Here we examine patterns of analgesic use
and their relationships to pain, self-efficacy and demographic factors.
Methods: Consecutive patients were approached in a hospital rheumatology out-patient clinic.
Pattern of analgesic use was assessed by response to statements such as 'I always take my tablets
every day.' Pain and self-efficacy (SE) were measured using the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) and Arthritis Self-Efficacy Scale (ASES). Influence of
factors on pain level and regularity of analgesic use were investigated using linear regression.
Differences in pain between those agreeing and disagreeing with statements regarding analgesic use
were assessed using t-tests.
Results: 218 patients (85% of attendees) completed the study. Six (2.8%) patients reported no
current pain, 26 (12.3%) slight, 100 (47.4%) moderate, 62 (29.4%) severe and 17 (8.1%) extreme
pain. In multiple linear regression self efficacy and regularity of analgesic use were significant (p <
0.01) with lower self efficacy and more regular use of analgesics associated with more pain.
Low SE was associated with greater pain: 40 (41.7%) people with low SE reported severe pain
versus 22 (18.3%) people with high SE, p < 0.001. Patients in greater pain were significantly more
likely to take analgesics regularly; 13 (77%) of those in extreme pain reported always taking their
analgesics every day, versus 9 (35%) in slight pain. Many patients, including 46% of those in severe
pain, adjusted analgesic use to current pain level. In simple linear regression, pain was the only
variable significantly associated with regularity of analgesic use: higher levels of pain corresponded
to more regular analgesic use (p = 0.003).
Conclusion: Our study confirms that there is a strong inverse relationship between self-efficacy
and pain severity. Analgesics are often used irregularly by people with arthritis, including some
reporting severe pain.
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Background
Arthritis is a highly prevalent condition and can lead to
physical impairments and psychological morbidity,
including depression, anxiety and feelings of helplessness
[1]. A long term need for analgesics and non-steroidal
anti-inflammatory drugs (NSAIDs) is common, with
many people also using non-pharmacological measures
and complementary therapies [2,3]. However, previous
research suggests that patients with arthritis commonly do
not take NSAIDs as prescribed; taking pain medication in
lower doses and less frequently than recommended [4].
Analgesics may be more effective for people with chronic
pain when taken regularly and pre-emptively, thus
decreasing the peak-and-trough effect of intermittent dos-
ing. This, at least theoretically, enables more continuous
pain relief [5] and reduces the likelihood of movement
related pain. Research into arthritis patients' use of pain
killers has traditionally focused on adherence to NSAIDs
[6]. Methods of measuring compliance have included
recording proportion of medication taken [7], assaying
drug levels [8], self-reported adherence [9-11] and record-
ing non-adherent behaviours such as missing doses [7]. In
chronic conditions such as arthritis analgesics may be pre-
scribed to be taken 'as needed' especially where the sever-
ity of pain fluctuates, so we have chosen to investigate the
pattern of patients' use of pain killers rather than their
actual adherence to prescribed regimens. In this study
'patterns' refers to the way in which people take analgesics
on a daily basis.
Self-efficacy is defined as an individual's judgement of
their capability to carry out a course of action required to
achieve a desired goal [12] and in this study refers to a
patient's perception of their ability to manage arthritis
and its symptoms. Higher self-efficacy scores have been
associated with better adherence to non-analgesic medica-
tion [13,14], lower pain intensity [15,16] and less func-
tional impairment [17-19]. The relationship between self
efficacy, pain and patterns of analgesic use is unclear. The
aims of this study were to explore patterns of analgesic use
among patients attending rheumatology clinics and the
relationship between analgesic use, self-efficacy, pain and
demographic characteristics.
Methods
Setting & Population
Our study was conducted in the outpatient rheumatology
clinics of Selly Oak Hospital, Birmingham, which were
provided by 11 clinicians. The majority of patients had
some form of arthritis; a minority had some form of soft
tissue musculoskeletal pain. Patients attending rheuma-
tology clinics suffer mostly from an inflammatory arthritis
and commonly endure skeletal pains from a variety of
causes, including secondary osteoarthritis and myofacial
pains [20]. We chose not to seek any further diagnostic
information as we were interested in this heterogeneous
population as a whole and the way these individuals
responded to musculoskeletal pain. The term arthritis will
be used in this article to describe the problems suffered by
our study population.
Consecutive patients with any form of arthritis or pain of
least 3 months duration and who were able to speak Eng-
lish were approached. Eligible patients were given an
information leaflet and those giving written consent were
asked to complete a questionnaire. Data were collected
over 4 weeks during February and March 2007. Patients
with a shorter history of arthritis were excluded because
we wished to study established patterns of analgesic use
and we believed that 3 months was a reasonable period
for these to develop. Questionnaires were self-completed
by 81.2% of patients. One researcher (RB) recorded the
responses of those unable to write either due to arthritis
affecting their hands or ability to speak but not write Eng-
lish.
Patients unable to complete questionnaires during their
visit to the clinic were given a reply paid pre-addressed
envelope and asked to return it by mail. Those who had
not returned their questionnaire within two weeks were
sent a reminder and a new questionnaire by mail (Figure
1).
Patient recruitment Figure 1
Patient recruitment.
 
  Total population: 317 
Eligible: 257 
Questionnaires 
completed in clinic: 209 
Questionnaires 
posted: 17 
Missed: 25  Ineligible: 35:- 
 
No arthritis: 6 
Diagnosed <3 months: 25 
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  Returned: 9  Reminded: 8 
Returned: 0  Questionnaires 
completed 218 (85%) 
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Questionnaires
Demographic data including gender, age, ethnicity (classi-
fied according to the 2001 census) [21] and duration of
arthritis were collected. The shorter 8-item version of the
Arthritis Self-Efficacy Scale (ASES) was used to assess self-
efficacy for managing arthritis [22]. The ASES has been
shown to have acceptable construct and concurrent valid-
ity and test-retest reliability [22]. The short-form version
has been demonstrated to have good psychometric char-
acteristics (high internal consistency [Cronbach's alpha =
0.89] and minimal floor and ceiling effects) [17]. In order
to make this questionnaire more understandable for Brit-
ish patients the word 'blue' in the phrase 'if you are feeling
blue' was replaced by the word 'low'. Each question of the
ASES self-efficacy scale was answered on a scale of 1 to 10
(1 being very uncertain - low self-efficacy; 10 being very
certain - high self-efficacy). The mean of the responses
gave the self-efficacy rating. Pain was assessed by using the
Western Ontario and McMaster Universities Osteoarthri-
tis Index (WOMAC) pain sub-scale. Each of 5 questions is
answered on a five point Likert scale (0 = no pain to 4 =
extreme pain), the summation of which gives the partici-
pant's pain score. The WOMAC scale is widely used and its
validity and reliability have been established in rheuma-
toid arthritis (RA) and osteoarthritis (OA) [23,24].
A series of statements was used to assess patients' pattern
of analgesic use. (Table 1) In this study the term 'analge-
sics' included paracetamol (acetaminophen), compound
analgesics (including paracetamol and codeine) and
NSAIDs. Standard measures of adherence, such as propor-
tion of medication taken, were not used in this study for
several reasons. Firstly it was our intention to investigate
how patients are using their analgesics, not simply if they
were taking a certain amount. Secondly analgesics are
often not prescribed to be taken a certain number of times
a day but 'as needed'. Also, patients in pain may not be
receiving prescription analgesics or NSAIDs but may be
taking over the counter preparations.
It was our aim to investigate how patients managed their
analgesics in relation to their pain and related factors such
as exercise and sleep. A recent study exploring osteoarthri-
tis patients' management of pain and analgesics found
that many patients varied their use of pain killers and were
often reluctant to take analgesics unless unable to tolerate
the pain [4]. Accordingly, statements relating to regular
use; use only in significant pain and varying use depend-
ing on level of pain were included in this study. Both oste-
oarthritis and rheumatoid arthritis can be characterised by
flare ups and remissions of symptoms. A statement relat-
ing to changes in analgesic use during flare ups was there-
Table 1: Pattern of analgesic use according to severity of pain
Statement Number (%) of patients agreeing* with statement in each pain category (score range)
None (n = 6)
(0 to <0.5)
Slight (n = 26)
(0.5 to <1.5)
Moderate (n = 100)
(1.5 to <2.5)
Severe (n = 62)
(2.5 to <3.5)
Extreme (n = 17)
(3.5 to 4)
1. I always take my tablets everyday 2 (33%) 9 (35%) 66 (65%) 47 (72%) 13 (77%)
2. I only take a tablet when the pain gets too 
bad
5 (83%) 14 (54%) 45 (45%) 23 (35%) 5 (29%)
3. I vary how I take the tablets depending on 
how bad the pain is
3 (50%) 14 (54%) 54 (54%) 30 (46%) 6 (35%)
4. When I'm having a bad patch I take my 
tablets everyday, otherwise I only take them 
when I feel I need them
3 (50%) 14 (54%) 44 (44%) 20 (31%) 3 (18%)
5. I usually take the tablets before I go to bed 1 (17%) 6 (23%) 37 (37%) 24 (37%) 9 (53%)
6. I usually take the tablets before exercise 1 (17%) 3 (12%) 34 (34%) 20 (31%) 4 (24%)
* Patients were given the following instruction: 'These questions are about how you take the PAIN KILLER medications the doctor is currently 
giving you for you arthritis. Please circle the number that describes how much you agree with the statement'.
Scores were: 1 = strongly disagree; 2 = moderately disagree; 3 = slightly disagree; 4 = slightly agree; 5 = moderately agree; 6 = strongly agree.
Statement Number (percentage) of participants who answered the question
1. 197 (90)
2. 193 (89)
3. 189 (87)
4. 193 (89)
5. 191 (88)
6. 184 (84)BMC Musculoskeletal Disorders 2009, 10:137 http://www.biomedcentral.com/1471-2474/10/137
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fore also included. Sale et al. [4] also found that many
patients had been advised to take analgesics before activ-
ity; however their participants did not report taking their
analgesics in this way. Pain can often cause sleeping prob-
lems for patients with arthritis. A study involving clients
from the Observational Arthritis Study in Seniors [25]
found that 81% of patients had problems with sleep
maintenance. We therefore also included statements
related to analgesic use before exercise and sleep. Descrip-
tors were discussed with clinicians and piloted by eight
patients before use; no changes were made as a result of
the pilot.
Patients recorded, on a 6-point Likert scale, whether they
agreed (strongly agree = 6) or disagreed (strongly disagree
= 1) with each statement. For questions where the more
strongly the patient agreed with the statement the less reg-
ularly they took their analgesics, e.g. 'I only take a tablet
when the pain gets too bad,' the scores were reversed. This
allowed high scores for all questions to relate to more reg-
ular analgesic use. The scores for the four questions
related to regularity of use (1-4 table 1) were then sum-
mated to provide an overall measure of how regularly
patients were using analgesics. The internal reliability of
the 'analgesic regularity' questionnaire was good, with a
Cronbach's alpha of 0.82. Inter-item correlations ranged
from 0.35 to 0.62 and item-total correlations from 0.49 to
0.74.
Ethical approval
Ethical approval was granted by the South Birmingham
Research Ethics Committee.
Statistical considerations and analyses
All data were entered into Microsoft Excel and statistical
analyses were performed in SPSS v15 for Windows. The
WOMAC pain scores were grouped into 5 categories based
on the original categories used to answer the pain ques-
tions: no pain (0-0.499), slight pain (0.5-1.499), moder-
ate pain (1.5-2.499), severe pain (2.5-3.499) and extreme
pain (3.5-4). The pattern of analgesic use at each level of
pain was examined. T-Tests were also used to examine the
differences in mean pain score between those agreeing
and disagreeing with statements regarding analgesic use.
As this involved multiple comparisons a more conserva-
tive significance level (p < 0.01) was used for these analy-
ses, otherwise p < 0.05 was used. To investigate the
relative influence of factors on regularity of analgesic use,
simple and multiple regression analyses were undertaken.
Firstly, simple regression analyses were undertaken
between the predictor variables. A significant relationship
was found between age and duration of the disease, but
both were retained in the model. Age, gender, ethnicity,
duration of disease, severity of pain and self-efficacy were
entered simultaneously into the model. Ethnicity was
entered as a binary variable (white British or other ethnic
group) due to the relatively small number of participants
from a minority ethnic group. An analysis of the residuals
identified that they were normally distributed, so the
assumptions for the model were met. Similar methods
were used to investigate the influence of age, gender, eth-
nicity, duration of disease, regularity of analgesic use and
self-efficacy on reported pain.
Results
Patient characteristics
Two hundred and eighteen patients completed question-
naires, providing a response rate of 85% (figure 1). The
mean age of participants was 55 years (SD 14.8), 155
(71%) were female and patients had had arthritis for a
median of 10 years (IQR 5, 20). Six (2.8%) patients
reported having no current pain, 26 (12.3%) described
their pain as slight, 100 (47.4%) moderate, 62 (29.4%)
severe and 17 (8.1%) extreme. A majority of patients were
white (183, 84%), twenty one (10%) Asian or British
Asian, seven (3%) were mixed race and seven (3%) had a
Black, or Black British background.
Use of analgesics
Use of paracetamol (acetaminophen) was reported by 65
(29.8%) of participants; compound analgesics (including
paracetamol and codeine) by 111 (50.9%) and NSAIDs
by 71 (32.6%).
Pattern of analgesic use
The majority of patients in extreme pain reported always
taking their analgesics everyday, falling to less than a third
of those in no pain. A large proportion of those in no (cur-
rent) pain and slight pain reported only taking analgesics
when they felt their pain was too severe, a practice less
common amongst those in greater pain; yet almost one
third of patients in extreme pain still only used analgesics
when their pain became 'too bad'. A large proportion of
patients with all severities of pain varied how they took
their analgesics depending on their level of pain. Patients
in slight or no pain were much more likely to only take
analgesics regularly during 'bad patches' than those in
extreme pain. Details are given in table 1.
The proportion of patients reporting taking analgesics
before bed increased with the level of pain suffered. There
was no distinct pattern in those who took analgesics
before exercise. Very few of those in slight or no pain took
analgesics before exercise compared with approximately
one third of those in moderate and severe pain and one
quarter of patients in extreme pain.
Patients who reported always taking their analgesics daily
had a higher mean pain score than those who did not
(details shown in table 2). Those who reported only tak-BMC Musculoskeletal Disorders 2009, 10:137 http://www.biomedcentral.com/1471-2474/10/137
Page 5 of 9
(page number not for citation purposes)
ing analgesics when the pain got too bad had a lower pain
score compared with those who did not. There was no sig-
nificant difference in pain severity between those who var-
ied how they took their analgesics depending on their
level of pain and those who did not. However, there was
a trend towards those who varied their analgesics in this
way having slightly lower pain scores. Patients who only
took their analgesics regularly when they were having a
bad patch reported less pain than those who did not. In
terms of pre-emptive analgesic use, patients taking their
tablets before bed reported higher pain scores than those
who did not, but this was not significant. There was no
significant difference in pain related to taking analgesics
before exercise.
Predictors of regularity of analgesic use
In simple linear regression, pain was the only variable sig-
nificantly associated with regularity of analgesic use: a
greater pain score (i.e. more pain) corresponded to more
regular analgesic use. With multiple linear regression only
pain was significantly associated with regularity of analge-
sic use (Table 3).
Predictors of pain severity
The degree of pain reported was not associated with age,
gender or duration of arthritis, but was significantly asso-
ciated with self-efficacy, regularity of analgesic use and
ethnicity. Greater self-efficacy corresponded to less pain.
Patients from ethnic minorities had an average pain score
of 12.4 compared to 10.9 (p = 0.034) for those of white
British ethnicity in simple linear regression (Table 3). In
multiple linear regression where age, gender, duration of
arthritis, ethnicity, regularity of analgesic use and self-effi-
cacy were entered simultaneously, lower self efficacy and
regular use of analgesics remained significantly associated
with more pain.
Specific self-management techniques
Patients commonly used other methods of managing
pain. Many used rest (180, 84%), exercise (116, 54%),
heat (101, 47%) or a bath or a spa (83, 38%). Forty two
(20%) were currently being treated by a physiotherapist
and 40 (19%) participants reported using a form of com-
plementary therapy.
Discussion
In this study we have explored the way in which patients
attending rheumatology clinics manage their analgesics,
and the relationships between pain, self-efficacy and how
regularly analgesics are used.
Previous studies indicate that patients with RA [26] and
OA [4] may be taking analgesics less frequently than pre-
scribed: a finding that was replicated in our study. We
found, however, that people in more pain tended to take
analgesics more regularly and pre-emptively (particularly
before sleep). (The size of the difference in WOMAC pain
scores between those agreeing and disagreeing with state-
ments regarding regularity of use is similar to that
obtained by analgesic medication in patients with arthritis
[27]). However, patterns of pre-emptive analgesic use
before exercise were more complex. Those with moderate
pain more frequently took medication before exercise
than those with slight pain, but those in severe pain were
less likely to do so, perhaps because exercise capacity was
limited in those with severe pain or our study may have
been underpowered to detect a difference. By contrast a
smaller but similar study of RA patients found no relation-
ship between pain and regularity of analgesic use [28].
Table 2: T-Tests exploring differences in reported pain between those agreeing and disagreeing with pain management strategies
Statement Agree with statement Disagree with statement
Mean pain score Standard deviation Mean pain score Standard deviation p-value
1. I always take my tablets everyday 12.0 3.9 9.6 4.6 <0.001
2. I only take a tablet when the pain gets too 
bad
10.4 4.3 12.2 3.9 0.003
3. I vary how I take the tablets depending on 
how bad the pain is
10.9 4.0 11.5 4.7 0.343
4. When I'm having a bad patch I take my 
tablets everyday, otherwise I only take them 
when I feel I need them
10.2 4.0 12.0 4.3 0.006
5. I usually take the tablets before I go to bed 12.0 4.0 10.6 4.4 0.034
6. I usually take the tablets before exercise 11.7 3.7 10.9 4.6 0.238BMC Musculoskeletal Disorders 2009, 10:137 http://www.biomedcentral.com/1471-2474/10/137
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In our study, a majority of patients (18, 64%) agreed with
the statement 'I always take my tablets everyday'. A large
proportion of patients, however, varied their use of anal-
gesics depending on their current level of pain; including
over a third of people reporting severe pain, who only
used their medication on demand, or at times when pain
was unbearable. This approach is at odds with recommen-
dations in guidelines for health professionals, in which
pre-emptive and regular use of analgesics is recommended
in order to prevent breakthrough and movement related
pain [29]. Recent draft guidance from the National Insti-
tute for Health and Clinical Excellence recognised the sur-
prising lack of data on how patients use analgesics in OA
[28,30]. Also surprisingly, publications for patients by
respected arthritis organisations provide no guidance on
how analgesics should be used [31], although it is relevant
that disease knowledge is poorly related to patients'
beliefs about medication [32]. Education and advice
about analgesic use is likely to be provided by clinicians
during normal clinical contacts. The clinic from which
these patients were drawn also ran education classes for
patients with newly diagnosed inflammatory arthritis.
However, it is likely that few of the patients in this study
Table 3: Factors affecting reported pain and regularity of analgesic use: Simple and multiple linear regression.
Variable Factors affecting regularity of analgesic use Factors affecting pain severity
Simple Linear Regression Multiple Linear Regression* Simple Linear Regression Multiple Linear 
Regression#
β
(9%% CI)
SE p value β
(95% CI)
SE p value β
(95% CI)
SE p value β
(95% CI)
SE p
value
Pain 0.35
(0.12 to 
0.58)
0.12 0.003 0.37
(0.11 to 
0.63)
0.13 0.006 - - - - - -
Self-efficacy -0.15
(-0.67 to 
0.38)
0.27 0.578 0.09
(-0.49 to 
0.67)
0.29 0.768 -0.85
(-1.13 to -
0.58)
0.14 <0.001 -0.82
(-1.13 to -
0.52)
0.16 <0.001
Gender 0.83
(-1.40 to 
3.06)
1.13 0.464 0.64
(-0.60 to 
2.87)
1.13 0.574 0.58
(-0.68 to 
1.84)
0.64 0.368 0.52
(-0.77 to 
1.80)
0.65 0.431
Age 0.04
-0.03 to 0.1)
0.03 0.245 0.04
(-0.03 to 
0.11)
0.04 0.308 0.01
(-0.03 to 
0.05)
0.02 0.53 0.01
(-0.03 to 
0.05)
0.02 0.541
Ethnicity 1.69
(-0.68 to 
4.07)
1.20 0.161 0.98
(-1.54 to 3.5)
1.28 0.446 1.46
(0.12 to 
2.81)
0.68 0.034 1.39
(0.04 to 
2.82)
0.73 0.057
Disease 
duration
0.04
(-0.05 to 
0.14)
0.05 0.4 0.03
(-0.08 to 
0.13)
0.05 0.629 -0.01
(-0.07 to 
0.05)
0.03 0.68 -0.01
(-0.07 to 
0.05)
0.03 0.769
Regularity of 
analgesic use
-- - -- -0 . 1 4
(0.05 to 
0.23)
0.05 0.003 0.12
(0.04 to 
0.21)
0.04 0.006
*Percentage of explained variance 3.7
Variables adjusted for: pain, self-efficacy, gender, age, ethnicity, disease duration
# Percentage of explained variance 13.5
Variables adjusted for: self-efficacy, gender, age, ethnicity, disease duration, regularity of analgesic useBMC Musculoskeletal Disorders 2009, 10:137 http://www.biomedcentral.com/1471-2474/10/137
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had recently attended such classes: the median duration
of arthritis in our population was 10 years.
Analgesic medication appears to be seen differently to
other medications in that purposeful dose restraint is
common and often seen as acceptable [4]. Patients may
have many reasons for limiting their intake of analgesics
in this way. A dislike of tablet taking despite, paradoxi-
cally, relatively common use of complementary medica-
tions has been previously found and is supported by our
study [4]. Fears about dependency have also been well
reported [4] and, in our experience, patients often express
concerns about developing tolerance to analgesics. Use of
regular medication is perceived by many people to indi-
cate a loss of autonomy and to imply weakness [33]. Lim-
iting analgesic consumption may, like the widespread use
of complementary therapies, reflect an affirmation of
autonomy or personal empowerment [34]. Beliefs and
concerns about medicines are reported to influence adher-
ence to medication. Indeed, medication beliefs have been
found to have a greater influence on adherence in chronic
illness than clinical and sociodemographic factors [35].
A variety of psychosocial factors are known to influence
pain severity, which in turn may influence patterns of
analgesic use. We found, like others [36], that patients
from ethnic minorities reported more pain. However,
only 35 (16%) patients from ethnic minorities were
included in our population. This also prevented us from
exploring the differences in pattern of analgesic use by
severity of pain in each ethnicity, as the number of
patients in each category was very small.
A measure of self efficacy was included in our analysis.
This is a task specific trait [15] which seeks to ascertain
how capable an individual believes they are of carrying
out a course of action or behaviour needed to achieve a
goal [12]; here, the management of their pain. The con-
cept of self-efficacy is widely accepted and acknowledged
to be important in the study of pain. We found, like others
[37], that patients with higher perceived self efficacy
reported less pain. Cross-sectional measurements of self-
efficacy are believed to be a meaningful indicator of daily
pain and coping, with greater self-efficacy often leading to
more effective pain coping mechanisms [28]. Indeed, peo-
ple with high levels of self efficacy (for pain) have
reported less pain then those with low self-efficacy when
subjected to painful stimuli in a laboratory [37]. Self effi-
cacy was not, however, associated with regularity of anal-
gesic use reported in our study, after the influence of pain
was taken into account. No other measures were included
in our study and whilst many have overlapping features,
other psychological measures may have provided more
insight into the reasons behind patterns of analgesic use.
The low variance explained by the multivariate models for
severity of pain (R213.5%) and for regularity of analgesic
use (R23.7%) highlight the fact that that other psycholog-
ical factors may be more influential. Beliefs about pain
and analgesics [38,39], coping mechanisms [28], depres-
sion [40,41], anxiety [41] and psychological stress [42]
may all be of importance in understanding patients' expe-
rience of arthritis, pain and their analgesic use.
Our study was cross-sectional and therefore has important
limitations particularly because we do not know whether
the patterns of analgesic use and perceived self efficacy,
remain stable and whether the correlations reported hold
true over time. To achieve a high response rate and gener-
alisability we focused on the factors relating to pain that
we were most interested in, such as self-efficacy. However
we acknowledge that the investigation of other factors
such as depression is important and may be worth further
study in the future. We did not assess the psychometric
properties of the patterns of analgesic use scale prior to its
use in this study. It was not our intention to develop a new
scale and to report the properties of this scale. We chose
our questions to gain an insight into how patients man-
aged their analgesics on a daily basis. A majority of ques-
tionnaires were self-completed (81%) but in 19% of cases
(41 participants) a researcher recorded the answers. The
most common reason for this was difficulty with writing
due to arthritis; only 3 of the 41 participants who were
assisted were from an ethnic minority. Considering that
16% of the total study population were from ethnic
minorities, problems in participants' ability to write Eng-
lish were not a significant factor in this study and are
unlikely to result in any bias. Important strengths of our
study were an excellent response rate, use of well validated
measures, a heterogeneous population, inclusion of con-
secutive patients and availability of a researcher to help
with clarification when patients were completing ques-
tionnaires.
Conclusion
We found that self-efficacy, regularity of analgesic use and
ethnicity influenced the degree of pain reported by
patients. The majority of patients in this hospital outpa-
tient sample (85%) reported moderate or more severe
pain. People with greater pain reported more regular anal-
gesic use but a large proportion of patients, including
some in severe pain, varied their consumption of analge-
sics greatly. This may be because of patients' beliefs and
concerns about medications. Health professionals who
recognise such concerns during consultations may be bet-
ter able to guide patients and encourage more optimal
patterns of analgesic use and promote better function.
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